CFDE Data Portal | Search LINC03069

	Label	Description
	LINC03069 Gene (Entity type)	ENSG00000267712 - long intergenic non-protein coding RNA 3069
	GSE183141 trichloroethylene macrophage 5 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE113369 p53 inhibition 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE159678 hydroxychloroquine 4 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE223893 SETD2 PARP inhibition kidney 1 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Breast 20-29 vs 50-59 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Prostate 20-29 vs 30-39 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Spleen 20-29 vs 50-59 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Ovary 20-29 vs 70-79 Up Gene Set (Entity type)	A Gene Set from GTEx
	GSE160762 E2A knockout 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS

LINC03069

ENSG00000267712 - long intergenic non-protein coding RNA 3069

GSE183141 trichloroethylene macrophage 5 v 1 human up

A Gene Set from LINCS

GSE113369 p53 inhibition 2 v 5 human up

A Gene Set from LINCS

GSE159678 hydroxychloroquine 4 v 7 human dn

A Gene Set from LINCS

GSE223893 SETD2 PARP inhibition kidney 1 v 10 human up

A Gene Set from LINCS

GTEx Breast 20-29 vs 50-59 Up

A Gene Set from GTEx

GTEx Prostate 20-29 vs 30-39 Up

A Gene Set from GTEx

GTEx Spleen 20-29 vs 50-59 Down

A Gene Set from GTEx

GTEx Ovary 20-29 vs 70-79 Up

A Gene Set from GTEx

GSE160762 E2A knockout 0 v 2 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.